GHK-Cu vs Matrixyl
Two topical peptides aimed at the same cell, the fibroblast, with plausible mechanisms, small effect sizes, and a shared dependence on whether anything crosses the skin barrier.
Short answer
Matrixyl rests on firmer ground than GHK-Cu, with human clinical data against only preclinical or minimal evidence, resting mostly on animal or lab work. Someone focused on topical anti-wrinkle use has trial data to go on with Matrixyl; GHK-Cu, marketed for skin and hair, is still an early-research option. Both are sold in cosmetic skin-care products.
GHK-Cu
Copper tripeptide
Real tissue-remodeling biology, mostly in-vitro and topical; a cosmetic signal, not systemic anti-aging proof.
Full GHK-Cu evidence reviewMatrixyl
Palmitoyl pentapeptide-4
A matrikine that signals fibroblasts to make collagen; small split-face trials show a modest wrinkle effect, but the evidence is thin, industry-linked and formulation-dependent.
Full Matrixyl evidence reviewGHK-Cu vs Matrixyl: head to head
- FDA status / approved use
GHK-Cu
Long-established cosmetic ingredient in skincare creams and serumsMatrixyl
Sold as a cosmetic skincare ingredient- Marketed for
GHK-Cu
Skin, hair, 'anti-aging'Matrixyl
Topical anti-wrinkle- Outcome areas
GHK-Cu
Skin / hair; Longevity / lifespanMatrixyl
Skin / hair- Evidence grade
GHK-Cu
Preclinical / minimalMatrixyl
Clinical data- How it works
GHK-Cu
Copper-binding tripeptide that stimulates collagen synthesis in lab studiesMatrixyl
Collagen fragment that signals skin fibroblasts to make more collagen- Route and dosing
GHK-Cu
Topical cream or serum; injected forms are also soldMatrixyl
Topical cream applied to the skin- Headline human result
GHK-Cu
Not establishedMatrixyl
Modest improvement in wrinkles and fine lines vs the untreated side in a 12-week split-face trial of 93 women- Strongest evidence
GHK-Cu
J Biomater Sci, 2008. Little or no controlled human outcome data for the marketed useGHK-Cu evidence reviewPubMed 18644225Matrixyl
Robinson, Int J Cosmet Sci 2005Matrixyl evidence reviewPubMed 18492182- Key safety signal
GHK-Cu
Injected form has no established dosing or long-term safety data; copper can be toxic in excessMatrixyl
Benign record as a cosmetic; occasional local skin irritation- How it is obtained
GHK-Cu
Sold in cosmetic skin-care productsMatrixyl
Sold in cosmetic skin-care products
| GHK-Cu | Matrixyl | |
|---|---|---|
| FDA status / approved use | Long-established cosmetic ingredient in skincare creams and serums | Sold as a cosmetic skincare ingredient |
| Marketed for | Skin, hair, 'anti-aging' | Topical anti-wrinkle |
| Outcome areas | Skin / hair; Longevity / lifespan | Skin / hair |
| Evidence grade | Preclinical / minimal | Clinical data |
| How it works | Copper-binding tripeptide that stimulates collagen synthesis in lab studies | Collagen fragment that signals skin fibroblasts to make more collagen |
| Route and dosing | Topical cream or serum; injected forms are also sold | Topical cream applied to the skin |
| Headline human result | Not established | Modest improvement in wrinkles and fine lines vs the untreated side in a 12-week split-face trial of 93 women |
| Strongest evidence | J Biomater Sci, 2008. Little or no controlled human outcome data for the marketed useGHK-Cu evidence reviewPubMed 18644225 | Robinson, Int J Cosmet Sci 2005Matrixyl evidence reviewPubMed 18492182 |
| Key safety signal | Injected form has no established dosing or long-term safety data; copper can be toxic in excess | Benign record as a cosmetic; occasional local skin irritation |
| How it is obtained | Sold in cosmetic skin-care products | Sold in cosmetic skin-care products |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
- Preclinical / minimal:
- Evidence is largely animal, in-vitro, or anecdotal. Little or no controlled human outcome data for the marketed use.
Our verdict
This is a genuine like-for-like comparison: both are topical cosmetic peptides that try to tell fibroblasts to build matrix. Matrixyl's KTTKS core is a fragment of type I collagen acting as a matrikine, and small split-face trials report measurable but modest improvement in fine lines and photoaged skin, with much of that work tied to the ingredient's commercial orbit. GHK-Cu has the deeper and older mechanistic literature, but it is mostly in vitro and animal, with human data confined to small cosmetic studies of copper-peptide creams. They have not been tested against each other, both are strongly formulation-dependent, and for wrinkles retinoids have a far deeper and more independent evidence base than either.
GHK-Cu fits if
Someone who wants the broader remodeling story and a long-established cosmetic ingredient with a reasonable safety record in serums and creams.
Matrixyl fits if
Someone who prefers the narrower, more directly tested claim, a controlled split-face signal on fine lines, layered as a low-irritation adjunct rather than a retinoid replacement.
GHK-Cu vs Matrixyl: common questions
- Is either GHK-Cu or Matrixyl FDA-approved?
- No. GHK-Cu is a long-established cosmetic ingredient in skincare creams and serums. Matrixyl is sold as a cosmetic skincare ingredient.
- Which has stronger human evidence, GHK-Cu or Matrixyl?
- Matrixyl. It has human clinical data (key source: Robinson, Int J Cosmet Sci 2005), while GHK-Cu has only preclinical or minimal evidence (key source: J Biomater Sci, 2008).
- What are the main safety concerns with GHK-Cu and Matrixyl?
- With GHK-Cu, injected form has no established dosing or long-term safety data; copper can be toxic in excess. Matrixyl has a benign record as a cosmetic; occasional local skin irritation.
Key studies behind each
GHK-Cu
- Pickart L. (2008). The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. PubMed 18644225
- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. PubMed 26236730
- Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. PubMed 29986520
- Dou Y, Lee A, Zhu L, et al. (2020). The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. PubMed 35083444
Matrixyl
- Katayama K, Armendariz-Borunda J, Raghow R, et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem. PubMed 8486721
- Robinson LR, Fitzgerald NC, Doughty DG, et al. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. PubMed 18492182
- Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. PubMed 19570099
- Mohammed YH, Yamada M, Lin LL, et al. (2014). Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. PLoS One. PubMed 25033398
The full evidence reviews
- GHK-Cu: the copper peptide between real skincare and overclaim
A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.
Updated August 2026
- Matrixyl: what the evidence says about the “collagen-boosting” peptide
Palmitoyl pentapeptide-4 (pal-KTTKS) is a collagen fragment that signals fibroblasts to make more matrix — the mechanism is real, the topical trials are small and modest, and it sits beside retinoids, not above them.
Updated August 2026
Where to get it
Where to get peptide therapy
Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm GHK-Cu availability before ordering.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
- Oak LongevityPartner
Low-cost sermorelin within a broader longevity stack
- HealthRXPartner
Compounded sermorelin within a broad longevity and weight-care menu
- Bodybuilding Health+Partner
Sermorelin from Bodybuilding.com's telehealth program
Provider reviews we publish: Live VitalCalifornia Trim ClinicDr. Gillis' Wellness CenterElitePhysiqMDEmbraceRXEvolve Telemed